{"nct_id":"NCT02128958","title":"Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2014-09","start_date_type":"ACTUAL","primary_completion_date":"2017-11-27","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-31","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CANF"]}